Parallax Volatility Advisers L.P. Takes $929,000 Position in Translational Development Acquisition Corp. (NASDAQ:TDACU)

Parallax Volatility Advisers L.P. bought a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 50,400 shares of the company’s stock, valued at approximately $929,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Tuttle Capital Management LLC bought a new stake in Translational Development Acquisition in the fourth quarter valued at approximately $461,000. Wealthspring Capital LLC bought a new position in shares of Translational Development Acquisition during the 4th quarter worth approximately $1,095,000. Yakira Capital Management Inc. acquired a new position in shares of Translational Development Acquisition during the 4th quarter worth approximately $1,106,000. Warberg Asset Management LLC bought a new stake in Translational Development Acquisition in the 4th quarter valued at $1,373,000. Finally, Radcliffe Capital Management L.P. acquired a new stake in Translational Development Acquisition during the 4th quarter valued at $2,204,000.

Translational Development Acquisition Stock Performance

NASDAQ:TDACU opened at $10.20 on Friday. The company has a fifty day moving average of $10.15. Translational Development Acquisition Corp. has a one year low of $10.00 and a one year high of $10.30.

About Translational Development Acquisition

(Free Report)

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.

Recommended Stories

Institutional Ownership by Quarter for Translational Development Acquisition (NASDAQ:TDACU)

Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.